Main content
More or Less: Antibiotics and the Problem of the Broken Market
Why big pharma won’t invest in new antibiotics.
If we don’t get new antibiotics, as they become more resistant it is likely that people will die. It’s a huge business but there’s a problem - pharmaceutical companies are reluctant to invest time and money to develop new antibiotics. But why not?
(Image: Computer artwork of bacteria - credit: Science Photo Library)
Last on
Tue 1 Mar 2016
15:23GMT
Â鶹ԼÅÄ World Service except East and Southern Africa, News Internet & West and Central Africa
Broadcast
- Tue 1 Mar 2016 15:23GMTÂ鶹ԼÅÄ World Service except East and Southern Africa, News Internet & West and Central Africa